Innotherapy Stock Annual Yield
| 246960 Stock | KRW 8,440 10.00 0.12% |
InnoTherapy fundamentals help investors to digest information that contributes to InnoTherapy's financial success or failures. It also enables traders to predict the movement of InnoTherapy Stock. The fundamental analysis module provides a way to measure InnoTherapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InnoTherapy stock.
InnoTherapy |
InnoTherapy Company Annual Yield Analysis
InnoTherapy's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, InnoTherapy has an Annual Yield of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
InnoTherapy Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InnoTherapy's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InnoTherapy could also be used in its relative valuation, which is a method of valuing InnoTherapy by comparing valuation metrics of similar companies.InnoTherapy is currently under evaluation in annual yield category among its peers.
InnoTherapy Fundamentals
| Return On Equity | -66.34 | |||
| Return On Asset | -0.13 | |||
| Operating Margin | (6.16) % | |||
| Current Valuation | 84.92 B | |||
| Shares Outstanding | 5.04 M | |||
| Shares Owned By Insiders | 28.30 % | |||
| Shares Owned By Institutions | 0.20 % | |||
| Price To Sales | 97.27 X | |||
| Revenue | 507.29 M | |||
| Gross Profit | 339.33 M | |||
| EBITDA | (3.23 B) | |||
| Net Income | (5.04 B) | |||
| Cash And Equivalents | 1.03 B | |||
| Cash Per Share | 375.11 X | |||
| Total Debt | 17.17 B | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 6.75 X | |||
| Cash Flow From Operations | (3.98 B) | |||
| Number Of Employees | 26 | |||
| Beta | 1.49 | |||
| Market Capitalization | 44.19 B | |||
| Total Asset | 31.88 B | |||
| Z Score | 1.2 | |||
| Net Asset | 31.88 B |
About InnoTherapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InnoTherapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InnoTherapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InnoTherapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InnoTherapy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InnoTherapy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will appreciate offsetting losses from the drop in the long position's value.Moving together with InnoTherapy Stock
| 0.74 | 102940 | Kolon Life Science | PairCorr |
| 0.68 | 074430 | Aminologics CoLtd | PairCorr |
| 0.82 | 023910 | Daihan Pharmaceutical | PairCorr |
| 0.85 | 047920 | HLB Pharmaceutical | PairCorr |
Moving against InnoTherapy Stock
The ability to find closely correlated positions to InnoTherapy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InnoTherapy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InnoTherapy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InnoTherapy to buy it.
The correlation of InnoTherapy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InnoTherapy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InnoTherapy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InnoTherapy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InnoTherapy Stock
InnoTherapy financial ratios help investors to determine whether InnoTherapy Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoTherapy with respect to the benefits of owning InnoTherapy security.